Table 1. Correlation between HBxΔ31, Maspin, RhoGDIα and CAPZB expression and clinicopathological features in human HCCs.

Characteristics	Tumor HBxΔ31 expression		P value	Tumor Maspin expression		P value	Tumor RhoGDIα expression		P value	Tumor CAPZB expression		P value
	Negative (34)	Positive (68)		Negative (52)	Positive (50)		Negative (55)	Positive (47)		Negative (62)	Positive (40)
Age (yr)	50.5 (7.9)	51.4 (8.1)		50.9 (8.1)	50.1 (8.5)		51.8 (8.2)	50.5 (8.9)		50.9 (8.4)	52.1 (8.1)
Gender
Male	25	51	0.421	45	39	0.642	39	37	0.198	40	36	0.559
Female	10	16		12	6		16	10		18	8
Serum AFP
<20ng/mL	15	27	0.887	37	26	0.121	33	30	0.195	35	26	0.87
≥20ng/mL	21	39		25	14		20	19		20	21
Cirrhosis
Absent	15	28	0.061	25	14	0.78	22	20	0.188	24	21	0.112
Present	20	39		33	30		30	28		31	26
Child-Pugh score
Class A	27	35	0.316	41	35	0.12	40	36	0.552	35	30	0.305
Class B	11	29		11	15		14	12		20	17
Tumor number
Single	25	37	0.306	38	36	0.632	35	36	0.145	40	32	0.411
Multiple	14	26		13	15		14	17		11	19
Tumor size
<5cm	28	39	0.205	42	37	0.78	40	32	O.558	44	30	0.553
≥5cm	14	31		10	13		18	12		15	13
Tumor encapsulation
Absent	10	25	0.078	21	20	0.065	19	21	0.894	22	18	0.059
Present	27	40		34	27		33	29		35	27
Microvascular invasion
Absent	23	38	0.052	40	28	0.001*	32	19	0.042*	30	21	0.762
Present	12	29		22	12		20	29		25	26
Tumor differentiation
I-II	21	40	0.061	30	25	0.049*	31	32	0.19	32	26	0.222
III-IV	11	30		19	28		21	18		20	24
Intrahepatic metastasis
Absent	10	31	0.001*	40	19	<0.001*	36	17	0.021*	32	15	0.012*
Present	18	43		32	11		29	20		35	20
TNM stage
I-II	22	46	0.059	36	28	0.12	32	34	0.106	30	35	0.114
III-IV	11	25		22	16		21	13		24	13

^*P<0.05